Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

Bibliographic Details
Main Authors:	Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, Arda Ulaş Mutlu, Muhammed Mustafa Atcı, Abdullah Sakin, İrem Öner, Havva Yeşil Çınkır, Melek Karakurt Eryılmaz, Dilek Çağlayan, Onur Yazdan Balçık, Nail Paksoy, Senem Karabulut, Derya Kıvrak Salim, Cemil Bilir, Miraç Özen, Melike Özçelik, Ali Arıcan, Baran Akagündüz, Ali İnal, Dinçer Aydın, Leyla Özer, Ahmet Gülmez, Nazım Serdar Turhal, Selin Aktürk Esen, Efnan Algın, Sinem Akbaş, Yakup İriağaç, Teoman Şakalar, Çağlar Ünal, Özlem Er, Şaban Seçmeler, Mustafa Bozkurt
Format:	Article
Language:	English
Published:	BMC 2024-01-01
Series:	BMC Cancer
Online Access:	https://doi.org/10.1186/s12885-024-11863-0

Similar Items

Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
by: Elif Şenocak Taşçı, et al.
Published: (2024-01-01)

Melanoma: BRAFi Rechallenge
by: Christoforos S. Kosmidis, et al.
Published: (2023-05-01)

The assessment of incidental thyroid lesions on 18F-fluorodeoxyglucose positron emission tomography/computed tomogrophy: A single centre experience
by: Efnan Algin, et al.
Published: (2017-07-01)

Vegan/Vejetaryen Lezzetleri: Kuzey Kıbrıs'ta Faaliyet Gösteren Restoranlar Örneği
by: Hande Akagündüz, et al.
Published: (2023-09-01)

First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer
by: Selin Aktürk Esen, et al.
Published: (2022-09-01)

Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study
by: Muhammed Mustafa Atcı, et al.
Published: (2021-04-01)

Çift Sağ Koroner Arter: İki Vakanın Sunumu
by: Fahriye Vatansever, et al.
Published: (2013-09-01)

Time to rechallenge primary prevention ICD guidelines
by: Bethany Wong, et al.
Published: (2022-12-01)

Efficacy of pembrolizumab rechallenge for metastatic urothelial carcinoma
by: Nobutaka Nishimura, et al.
Published: (2022-09-01)

Bell's palsy during rechallenge of immune checkpoint inhibitor
by: Kohji Takemura, et al.
Published: (2023-03-01)

Dysphonia after Bevacizumab Rechallenge: A Case Report
by: Corey A. Carter, et al.
Published: (2015-10-01)

Effective long-term temozolomide rechallenge in a macroprolactinoma
by: Benedetta Zampetti, et al.
Published: (2018-10-01)

Rechallenge of voriconazole successfully tolerated after hepatic toxicity
by: O. Narumoto, et al.
Published: (2020-01-01)

Predictive Factors of Complete Tumor Response to First Line Chemotherapy in Patients with Extensive-stage Small Cell Lung Cancer
by: Eyyüp Çavdar, et al.
Published: (2022-06-01)

Abdominal wall perforation in a patient with recurrent epithelial ovarian cancer after bevacizumab treatment
by: Efnan Algin, et al.
Published: (2016-08-01)

Sprain Injury in a Child: Where is the Fracture Line?
by: Asim KALKAN, et al.
Published: (2014-03-01)

Thrombocytopenia with quetiapine: two case reports, one with positive rechallenge
by: Alexandre Lalli, et al.
Published: (2015-12-01)

Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer
by: Cedric Pobel, et al.
Published: (2021-09-01)

PEGylated Liposomal Doxorubicin Rechallenge following Doxorubicin-induced Pancreatitis
by: Luke Ardolino, et al.
Published: (2020-12-01)

Non-recurrence of carbamazepine induced vitiligo after rechallenge with carbamazepine.
by: Masoomeh Saeedloo, et al.
Published: (2013-12-01)

Prevalence of bruxism in Istanbul primary school children and association with the age groups
by: Sedat Aydın, et al.
Published: (2010-06-01)

Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer
by: Davide Ciardiello, et al.
Published: (2021-04-01)

Cetuximab Rechallenge and Monotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck
by: Greg Knutzen, et al.
Published: (2015-11-01)

Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
by: Kapil G. Kapoor, et al.
Published: (2017-07-01)

Immune Checkpoint Inhibitor-Induced Gastroduodenitis: Recurrence after Rechallenge with Pembrolizumab
by: Catarina O’Neill, et al.
Published: (2021-04-01)

Factors affecting survival in operated pancreatic cancer: Does tumor localization have a significant effect on treatment outcomes?
by: Abdullah Sakin, et al.
Published: (2020-10-01)

Comparison of apparent diffusion coefficient values among different MRI platforms: a multicenter phantom study
by: Ali Sami Kıvrak,, et al.
Published: (2013-11-01)

Evaluation of the Clinical Efficacy of Using Thermal Camera for Cryotherapy in Patients with Total Knee Arthroplasty: A Prospective Study
by: Zekeriya Okan Karaduman, et al.
Published: (2019-09-01)

An Extremely Rare Cause of Wolff-Parkinson-White Syndrome: Rhabdomyoma in Association With Tuberous Sclerosis
by: Özlem Elkıran, et al.
Published: (2019-03-01)

Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge
by: Federica Frascaro, et al.
Published: (2023-12-01)

Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer
by: Gen Lin, et al.
Published: (2024-02-01)

Efficacy of NSCLC Rechallenge with Immune Checkpoint Inhibitors following Disease Progression or Relapse
by: Maria Effrosyni Livanou, et al.
Published: (2024-03-01)

Axitinib Rechallenge Restores the Anticancer Effect after Nivolumab: A Case Report
by: Yueh-Shih Chang, et al.
Published: (2023-07-01)

The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge—A Systematic Review
by: Adrian Perdyan, et al.
Published: (2023-07-01)

Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report
by: Yuto Terashima, et al.
Published: (2022-12-01)

Osimertinib‐related liver injury with successful osimertinib rechallenge: A case report
by: Yuan‐Ling Cheng, et al.
Published: (2022-08-01)

Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide
by: Edward Silva, et al.
Published: (2020-06-01)

Ofloxacin-ornidazole fixed-dose combination medication-induced pancreatitis with positive rechallenge
by: Nikhil Bush, et al.
Published: (2020-01-01)

CLOZAPINE RECHALLENGE WITH LITHIUM AFTER DOUBLE INDUCED NEUTROPENIA: A CASE REPORT
by: A. Kourti, et al.
Published: (2019-01-01)

Effectiveness of EGFR‐TKI rechallenge immediately after PD‐1 blockade failure
by: Kyoichi Kaira, et al.
Published: (2021-03-01)